Epicore BioNetworks IncTSXV: EBN

Epicore Acquires Eastampton Site

· Issued by Epicore BioNetworks Inc via CNW
CALGARY, Sept. 14 /CNW/ - The Board of Directors of Epicore BioNetworks
Inc. is pleased to announce that the Company has acquired ownership of its
main business site in Eastampton, New Jersey, USA. Since the Company's
inception Epicore's research and manufacturing have been conducted in
Eastampton. Since 1999 corporate management and marketing operations have been
centered at the site. During this period the Company leased the facility. The
Company formed a limited liability realty partnership with an adjacent
business to purchase the combined site for US$1.4 million. Financing was
secured from Epicore's main US bank, Wachovia.
The acquisition provides security for Epicore operations and offers
operating costs savings. The acquisition is supported by Epicore's growing and
profitable international aquaculture business. Further, the acquisition is key
to the Company's plans to expand its North American business in the
environmental market.
Epicore BioNetworks Inc. announces that it has granted stock options to
directors and employees of the company. The number of options granted is
992,500, which is equivalent to 4.2% of Epicore's issued common stock. Under
the terms of the Epicore Stock Option Plan, options may be issued from time to
time in any amount up to 10% of the issued and outstanding Epicore common
shares. These options have an exercise price of $0.10 and expire in five
years. The grant to directors follows Company board compensation policy.
The grant includes additional options to Mr. D'Addario, who has agreed to
lead a new company division that will develop business for the company in the
environmental field. This role is in addition to his regular board duties. The
grant is subject to the receipt of the approval of the TSX Venture Exchange.

Epicore BioNetworks Inc. is a leading producer of environmental
biotechnology and animal nutrition products. It manufactures in the USA and
markets worldwide to a variety of industries to reduce environmental pollution
and increase operational productivity. Epicore is a major supplier to the
shrimp aquaculture industry.

Epicore BioNetworks Inc. is a public corporation with a registered office
in Calgary, Alberta, Canada and with shares listed on the Canadian Venture
Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not
accept responsibility for the adequacy or accuracy of this release.)


Epicore BioNetworks Inc on 6ix

Earlier from Epicore BioNetworks

Later from Epicore BioNetworks

All Epicore BioNetworks news releases